Prevalence and outcome of headache in tuberculous meningitis

References

1. ↵
   1. Garg RK

   (1999) Tuberculosis of the central nervous system. Postgrad Med J 75, 133–140.
2. ↵
   1. Hosoglu S,
   2. Geyik MF,
   3. Balik I,
   4. Aygen B,
   5. Erol S,
   6. Aygencel TG,
   7. et al.

   (2002) Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 6, 64–70.
3. ↵
   1. Sinha MK,
   2. Garg RK,
   3. Anuradha Hk,
   4. Agarwal A,
   5. Singh MK,
   6. Verma R,
   7. et al.

   (2010) Vision impairment in tuberculous meningitis: Predictors and prognosis. J Neurol Sci 290, 27–32.
4. 1. Anuradha HK,
   2. Garg RK,
   3. Agarwal A,
   4. Sinha MK,
   5. Verma R,
   6. Singh MK,
   7. et al.

   (2010) Predictors of stroke in patients of tuberculous meningitis and its effect on the outcome. QJM 103, 671–678.
5. ↵
   1. Raut T,
   2. Garg RK,
   3. Jain A,
   4. Verma R,
   5. Singh MK,
   6. Malhotra HS,
   7. et al.

   (2013) Hydrocephalus in tuberculous meningitis: Incidence, its predictive factors and impact on the prognosis. J Infect 66, 330–337.
6. 1. Singh B,
   2. Garg RK,
   3. Singh MK,
   4. Verma R,
   5. Malhotra HS,
   6. Jain A,
   7. et al.

   (2012) Computed tomography angiography in patients with tuberculous meningitis. J Infect 64, 565–572.
7. ↵
   1. Thwaites G,
   2. Fisher M,
   3. Hemingway C,
   4. Scott G,
   5. Solomon T,
   6. Innes J

   (2009) British Infection Society British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 59, 167–187.
8. ↵
   1. Marais S,
   2. Thwaites G,
   3. Schoeman JF,
   4. Török ME,
   5. Misra UK,
   6. Prasad K,
   7. et al.

   (2010) Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis 10, 803–812.
9. ↵
   1. British Medical Research Council

   (1948) Streptomycin treatment of tuberculous meningitis. BMJ 1, 582–596.
10. ↵
    1. Breivik H,
    2. Borchgrevink PC,
    3. Allen SM,
    4. Rosseland LA,
    5. Romundstad L,
    6. Hals EK,
    7. et al.

    (2008) Assessment of pain. Br J Anaesth 101, 17–24.
11. ↵
    1. World Health Organization

    (2010) Treatment of tuberculosis: guidelines (WHO, Geneva (CH)), 4th ed, Available from: http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf. Accessed 17 October 2012.
12. ↵
    1. Thwaites GE,
    2. Nguyen DB,
    3. Nguyen HD,
    4. Hoang TQ,
    5. Do TT,
    6. Nguyen TC,
    7. et al.

    (2004) Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351, 1741–1751.
13. ↵
    1. Headache Classification Committee of the International Headache Society

    (2004) Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 24, 155–156.
14. ↵
    1. Strassman AM,
    2. Raymond SA

    (1997) On the origin of headaches. Endeavour 21, 97–100.
15. ↵
    1. Mastroianni CM,
    2. Paoletti F,
    3. Lichtner M,
    4. D’Agostino C,
    5. Vullo V,
    6. Delia S

    (1997) Cerebrospinal fluid cytokines in patients with tuberculous meningitis. Clin Immunol Immunopathol 84, 171–176.
16. ↵
    1. Thwaites GE,
    2. Simmons CP,
    3. Than Ha Quyen N,
    4. Thi Hong Chau T,
    5. Phuong Mai P,
    6. Thi Dung N,
    7. et al.

    (2003) Pathophysiology and prognosis in vietnamese adults with tuberculous meningitis. J Infect Dis 188, 1105–1115.
17. ↵
    1. Kindler V,
    2. Sappino AP,
    3. Grau GE,
    4. Piguet PF,
    5. Vassalli P

    (1989) The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56, 731–740.
18. ↵
    1. Sáez-Llorens X,
    2. Ramilo O,
    3. Mustafa MM,
    4. Mertsola J,
    5. McCracken GH Jr.

    (1990) Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J Pediatr 116, 671–684.
19. ↵
    1. Saukkonen K,
    2. Sande S,
    3. Cioffe C,
    4. Wolpe S,
    5. Sherry B,
    6. Cerami A,
    7. et al.

    (1990) The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med 171, 439–448.
20. ↵
    1. Rock RB,
    2. Hu S,
    3. Gekker G,
    4. Sheng WS,
    5. May B,
    6. Kapur V,
    7. et al.

    (2005) Mycobacterium tuberculosis-induced cytokine and chemokine expression by human microglia and astrocytes: effects of dexamethasone. J Infect Dis 192, 2054–2058.
21. ↵
    1. Clark IA,
    2. Jacobson LS

    (1998) Do babesiosis and malaria share a common disease process? Ann Trop Med Parasitol 92, 483–488.
22. ↵
    1. Misra UK,
    2. Kalita J,
    3. Maurya PK

    (2011) Stroke in tuberculous meningitis. J Neurol Sci 303, 22–30.